3SBio, a China partner of U.S. drug giant Pfizer, has reached agreements to raise approximately $400 million in a share ...

Holmes’ attack on evidence that led to her conviction comes amid an apparent campaign to obtain a pardon from President ...

Pfizer's expanding oncology portfolio, rising sales of key therapies, and steady pipeline progress reinforce its long-term cancer strategy momentum.

These five stocks are potential total return champions that could offer investors a smooth ride in 2026, as we could see some ...

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.

Pfizer's strategy that will help it rebound from recent struggles is in full motion. It says a lot that the company continues ...

Shares of prominent vaccine makers Moderna MRNA, BioNTech BNTX, Pfizer PFE, Novavax NVAX and Vaxcyte PCVX fell on Monday after the FDA announced plans to impose strict new vaccine requirements. What’s ...

Infectious diseases specialist says we will see a serious flu season and the vaccine is still ‘very helpful’, and also COVID ...

Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam Pharmaceuticals.

TrumpRx.gov is a proposed website that could allow consumers to purchase brand-name prescription drugs directly from the manufacturer or through an affiliated online distributor at a lower price ...

Pfizer's concerted effort to move beyond its pandemic-era business and establish a new growth foundation in oncology faced an unexpected challenge this week. A revelation concerning regulatory ...